Latest Science Pfizer, BioNTech COVID-19 vaccine planned for late November FDA submission The first coronavirus 2019 (COVID-19) vaccine to be considered for emergency approval may be a month away. Pfizer chief executive officer Albert Bourla wrote in an open letter Friday morning that efficacy and safety... 20 October, 20203 min read